568th MEETING, ABERDEEN 77 1 is strictly non-competitive with 3-phospho-~-glycerate at the catalytic centre and strictly competitive with the corresponding MgATP2-. Analogous product-inhibition patterns were previously obtained with ADP, being non-competitive with MgATPZ-and competitive with 3-phospho-~-glycerate (Larsson-Rainikiewicz & Arvidsson, 1971). ADP and 1,3-diphospho-~-glycerate appear preferentially to bind to sites that are involved in the substrate activation observed at elevated concentrations of MgATP2-or 3-phospho-D-glycerate. The kinetic properties of the enzyme offer possibilities for the substrates, even at 'low' concentrations, to control very effectively the direction of the reversible reaction under, for example, conditions in vivo. Dihydrofolate reductase (tetrahydrofolate-NADP+ oxidoreductase, EC 1.5.1.3) is of considerable pharmacological interest as the site of action of the 'anti-folates', a group of powerful chemotherapeutic agents which includes methotrexate, trimethoprim and pyrimethamine. The essential structural feature of these inhibitors is the replacement of theCoxo group of the substrate, folate, by an amino group; this substitution leads to an increase in affinity for the enzyme by a factor of approx. lo4. In searching for an explanation for this large increase in affinity, Baker (1959Baker ( , 1967 and Pullman and co-workers (Perault & Pullman, 1961 ; Collin & Pullman, 1964) drew attention to the increased basicity of the N-1 position, which accompanies the change from the 4-0x0 to the 4-amino form, and Baker (1959Baker ( , 1967 proposed that the inhibitors, but not the substrates, bound to the enzyme in the protonated form.
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It has been pointed out (Erickson & Mathews, 1972; Poe et al., 1974) that the U.V. difference spectrum generated when methotrexate binds to the enzyme has ageneral similarity to the protonation difference spectrum of methotrexate. We have undertaken a quantitative analysis of the pH-dependence of the U.V. difference spectra generated by the binding of methotrexate or trimethoprim to Lactobacillus casei dihydrofolate reductase. This analysis allows us to determine the pK values of the bound ligands. The pK of methotrexate (for protonation at N-1) is increased by approx. 3 units on binding to the enzyme, i.e. the protonated form of methotrexate binds about 1000-fold more tightly than does the neutral form. For trimethoprim the results are qualitatively similar, but the increase in pK on binding is significantly less. In both cases it is also possible to identify features in the difference spectrum which are not associated with protonation of the ligand, notably a tryptophan perturbation, and, with methotrexate, an absorption band centred at 330nm, which is red-shifted on binding. These features are responsible for the differences between the enzymebinding and the protonation difference spectra.
In contrast, the difference spectra which accompany the binding of the substrates folate and dihydrofolate are pH-independent over the range pH 5-8.5. This, taken
The structure of cat muscle pyruvate kinase has been determined to 0.60nm (6.0A) resolution (Stammers & Muirhead, 1975) , and more recently to a higher resolution (H. Muirhead, personal communication). The enzyme has mol.wt. 240000 and consists of four very similar or identical subunits. Chemical-modification studies have indicated that a thiol group is essential for the catalytic activity of rabbit muscle pyruvate kinase (Flashner et al., 1972; Chalkley & Bloxham, 1976) . Evidence is presented in this communication that under the appropriate conditions, a thiol-group-containing peptide of cat muscle pyruvate kinase is preferentially labelled with i~do['~C]acetic acid.
Cat muscle pyruvate kinase was purified by the method of Stammers & Muirhead (1975) , and the purity of the enzyme product was established by polyacrylamide-gel electrophoresis in 1 % sodium dodecyl sulphate. The enzyme was labelled with i~do['~C]-acetic acid under two different sets of conditions, and the CNBr fragments were separated by gel filtration on coupled columns of Sephadex G-50 and G-25 (Fig. 1 ). For complete labelling of the thiol groups the following conditions were used: 20mg of pyruvate kinase was dialysed for 18 h against 2 litres of distilled water and freeze-dried. The enzyme was dissolved in 2.5ml of O.S~-Tris/Hc1, pH8.5, containing 5nm-dithiothreitol, ~~M -E D T A and recrystallized 8~-u r e a . The enzyme solution was as described in the text. The labelled enzyme was treated with CNBr, and the fragments were separated by gel chromatography in 50% (v/v) formic acid as described for (a). The horizontal line indicates background radioactivity. 0 , Radioactivity; 0, A2,6.
